Literature DB >> 26692294

The thorough QT study - do we need more of the same?

Yoon K Loke1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26692294      PMCID： PMC4767199          DOI： 10.1111/bcp.12871

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  The cost-effectiveness of drug regulation: the example of thorough QT/QTc studies.

Authors:  J C Bouvy; M A Koopmanschap; R R Shah; H Schellekens
Journal:  Clin Pharmacol Ther       Date:  2011-12-28       Impact factor: 6.875

2.  The thorough QT study - do we need more of the same?

Authors:  Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2016-02-17       Impact factor: 4.335

Review 3.  The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance.

Authors:  Borje Darpo
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

4.  Utility of concentration-effect modeling and simulation in a thorough QT study of losmapimod.

Authors:  April M Barbour; Mindy Magee; Bonnie Shaddinger; Niki Arya; Lee Tombs; Wenli Tao; Bela R Patel; Michael J Fossler; Ruchira Glaser
Journal:  J Clin Pharmacol       Date:  2015-02-13       Impact factor: 3.126

5.  Implications of the IQ-CSRC Prospective Study: Time to Revise ICH E14.

Authors:  Borje Darpo; Christine Garnett; James Keirns; Norman Stockbridge
Journal:  Drug Saf       Date:  2015-09       Impact factor: 5.606

6.  QTc prolongation as a surrogate for drug-induced arrhythmias: fact or fallacy?

Authors:  Luc M Hondeghem
Journal:  Acta Cardiol       Date:  2011-12       Impact factor: 1.718
  6 in total
  2 in total

1.  The thorough QT study - do we need more of the same?

Authors:  Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2016-02-17       Impact factor: 4.335

2.  Balancing the Need for Personalization of QT Correction and Generalization of Study Results: Going Beyond Thorough QT Studies.

Authors:  Igor Diemberger; Emanuel Raschi; Gianluca Trifirò
Journal:  Clin Drug Investig       Date:  2017-10       Impact factor: 2.859
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.